Acutus Medical is an arrhythmia management company. Co. designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Co.'s product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters (available only in its European markets), mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Co.'s primary product is its AcQMap imaging and mapping system, which provides a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias with unmatched speed and precision. We show 15 historical shares outstanding datapoints in our AFIB shares outstanding history coverage, used to compute AFIB market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AFIB market cap history over the course of time is important for investors
interested in comparing AFIB's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AFIB versus a peer is one thing; comparing
AFIB market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AFIB can fluctuate over the course of history.
With this page we aim to empower investors researching AFIB by allowing them to research the AFIB market cap history. |
Free AFIB Email Alerts:
Video: The Importance of Market Cap
